Journal Guides6 min readUpdated Apr 21, 2026

European Heart Journal SJR and Scopus Metrics: What They Actually Mean

European Heart Journal still has flagship cardiology metrics, but the real submission question is whether your paper is broad enough for that readership.

Author contextAssistant Professor, Cardiovascular & Metabolic Disease. Experience with Circulation, European Heart Journal, Cell Metabolism.View profile

Next step

Choose the next useful decision step first.

Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.

Open Journal Fit ChecklistAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness ScanOr find your best-fit journal in 30 seconds
Journal context

European Heart Journal at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor35.6Clarivate JCR
Acceptance rate~10%Overall selectivity
Time to decision~20 daysFirst decision

What makes this journal worth targeting

  • IF 35.6 puts European Heart Journal in a visible tier — citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~~10% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
  • If timeline matters: European Heart Journal takes ~~20 days. A faster-turnaround journal may suit a grant or job deadline better.
  • If open access is required by your funder, verify the journal's OA agreements before submitting.

Quick answer: European Heart Journal still has flagship-level Scopus authority in cardiology. Current Scopus-based sources place it at SJR 4.987, impact score 7.46, global rank 295, and h-index 367 in 2024. That confirms top-tier field influence. The hard submission question is not whether the journal is strong. It is whether the manuscript has broad enough cardiovascular consequence for a field-wide readership rather than a narrower subspecialty audience.

Direct answer

If your question is whether European Heart Journal still behaves like a true cardiology flagship in the Scopus system, the answer is yes.

Metric
Current value
What it tells you
SJR
4.987
prestige-weighted influence remains elite for cardiology
Impact Score
7.46
citation density is still strong and durable
Global rank
295
the journal remains near the top of the full global ranking
h-index
367
the archive has deep long-run field influence
Best quartile
Q1
the title remains firmly top-tier
Coverage history
1980-2025
this is durable flagship authority, not a short-lived peak

That profile matters because EHJ is not only a society brand. It remains one of the main journals cardiologists use to benchmark broad field consequence.

Overview

The useful summary is that European Heart Journal is still in the flagship cardiology lane, but the current 2024 profile looks stronger than the softer 2022-2023 stretch. The SJR is up from 4.091 in 2023, and the impact score is up from 6.58. That tells you the title is recovering strength within the same high-end band rather than drifting out of it.

What changed in 2024

The 2024 picture is meaningfully better than the prior two years.

  • SJR moved up from 4.091 in 2023 to 4.987 in 2024
  • impact score moved up from 6.58 to 7.46
  • global rank improved from 396 to 295

That matters because it confirms the journal's field authority remains intact. For authors, the implication is that the flagship screen is still real.

Ten-year SJR and Scopus trend

Year
SJR
Impact Score
Global Rank
2024
4.987
7.46
295
2023
4.091
6.58
396
2022
3.450
6.48
481
2021
4.118
6.52
368
2020
4.336
5.45
351
2019
5.883
5.49
214
2018
6.788
7.08
169
2017
9.315
8.06
89
2016
7.285
8.04
151
2015
7.264
7.75
144
2014
6.807
9.01
168

The trend shows a journal that remains in the flagship cardiology band even though its prestige weighting is lower than its 2017 peak. The 2024 rebound matters because it ends the impression that EHJ is still drifting downward.

What the trend means in practice

For authors, the trend usually means:

  • EHJ still expects papers with broad cardiovascular reach
  • the journal remains strong enough that narrow papers look narrow quickly
  • the readership is broad across cardiology, not only one disease or technique lane
  • a very good specialist paper is not automatically an EHJ paper

That is why the journal can reject excellent cardiovascular work that still lacks field-wide consequence.

How European Heart Journal compares with realistic neighbors

Journal
Relative 2024 profile
What the metric profile usually signals
European Heart Journal
SJR 4.987
flagship cardiology journal with very broad readership
Circulation
higher prestige weighting than EHJ
similarly broad field-wide decision lane
JACC
same flagship cardiology lane
top-field option for high-consequence cardiovascular work
specialty cardiology journals
materially lower prestige concentration
better fit when the audience is narrower or more technical

This is the useful comparison. EHJ still sits in the rare top-cardiology room even if the exact metric shape differs from Circulation or JACC.

What editors are really screening for

The official journal description is direct:

  • the highest quality material
  • both clinical and scientific work
  • all aspects of cardiovascular medicine
  • research broad enough to matter to the field

That is why the profile remains strong. EHJ is not merely rewarding topic heat. It is still rewarding wide cardiovascular relevance.

In Our Pre-Submission Review Work on European Heart Journal Metric Questions

In our pre-submission review work on European Heart Journal metric questions, three mistakes recur.

The subspecialty prestige mistake. Authors often treat EHJ as the obvious destination for any strong cardiology paper even when the audience is actually much narrower.

The practice-consequence mistake. Another common miss is a technically clean study with insufficient implication for broader cardiovascular practice or field understanding.

The society-halo mistake. We also see teams lean on the ESC connection and the journal's reputation to substitute for honest fit analysis. The SJR confirms authority. It does not rescue a paper that belongs in a more specialized cardiovascular venue.

That is the practical value of the metrics. They explain why EHJ can preserve a broad, demanding audience standard.

What these metrics mean for authors

For authors, the current profile says:

  • publication here still carries major field-wide cardiology signal
  • the archive is strong enough that weak audience fit becomes obvious quickly
  • the journal rewards breadth of cardiovascular consequence more than local excellence
  • if the manuscript truly fits, the visibility upside remains substantial

The h-index of 367 matters because it reflects a deep archive of widely reused cardiovascular papers rather than a narrow specialty footprint.

Submit If / Think Twice If

Submit if:

  • the manuscript matters across the broader cardiovascular field
  • the study has obvious clinical or scientific consequence beyond one slice of cardiology
  • the work would attract attention outside one narrow technical lane
  • the paper still looks important after you strip away prestige language

Think twice if:

  • the paper is strong but mainly relevant to one subspecialty audience
  • the practical or field-wide consequence still feels indirect
  • the manuscript is more technical than broad in appeal
  • a more specialized cardiology journal is the honest fit

Readiness check

Run the scan while the topic is in front of you.

See score, top issues, and journal-fit signals before you submit.

Get free manuscript previewAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr run a stats sanity check

What should drive the decision after the metrics check

The better question is whether the manuscript is truly an European Heart Journal paper in its current form.

That is why the next useful reads are:

If the study has broad cardiovascular consequence, the upside is real. If it is still too narrow, the metrics are mostly a warning against over-targeting. A European Heart Journal submission framing check is the fastest way to pressure-test that before submission.

Practical verdict

European Heart Journal still has a genuine flagship Scopus profile for cardiology, and the 2024 rebound confirms that it remains solidly in that tier.

For authors, the metric question is already settled. The live question is whether the manuscript is broad enough for the readership the journal actually serves.

  1. European Heart Journal impact factor, Manusights.

Frequently asked questions

European Heart Journal's 2024 SJR is 4.987 on current Scopus-based metric aggregators, which keeps it firmly in Q1 and in the flagship cardiology tier.

Current Scopus-based sources place European Heart Journal's 2024 impact score at 7.46, with a global rank of 295 and h-index of 367.

Because it remains one of the central journals in cardiovascular medicine, with broad clinical visibility across the European and global cardiology community.

No. The real question is whether the manuscript has broad enough cardiovascular consequence for a flagship ESC-linked audience.

References

Sources

  1. 1. European Heart Journal metrics page, Resurchify.
  2. 2. About the Journal | European Heart Journal, Oxford Academic.
  3. 3. European Heart Journal impact page, Oxford Academic.

Before you upload

Choose the next useful decision step first.

Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.

Use the scan once the manuscript and target journal are concrete enough to evaluate.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Journal Fit Checklist